Abstract:Background: In this study, we examined the length of stay (LoS)-predictive comorbidities, hospital costs-predictive comorbidities, and mortality-predictive comorbidities in immobile ischemic stroke (IS) patients; second, we used the Charlson Comorbidity Index (CCI) to assess the association between comorbidity and the LoS and hospitalization costs of stroke; third, we assessed the magnitude of excess IS mortality related to comorbidities. Methods: Between November 2015 and July 2017, 5114 patients hospitalized for IS in 25 general hospitals from six provinces in eastern, western, and central China were evaluated. LoS was the period from the date of admission to the date of discharge or date of death. Costs were collected from the hospital information system (HIS) after the enrolled patients were discharged or died in hospital. The HIS belongs to the hospital's financial system, which records all the expenses of the patient during the hospital stay. Cause of death was recorded in the HIS for 90 days after admission regardless of whether death occurred before or after discharge. Using the CCI, a comorbidity index was categorized as zero, one, two, and three or more CCI diseases. A generalized linear model with a gamma distribution and a log link was used to assess the association of LoS and hospital costs with the comorbidity index. Kaplan-Meier survival curves was used to examine overall survival rates. Results: We found that 55.2% of IS patients had a comorbidity. Prevalence of peripheral vascular disease (21.7%) and diabetes without end-organ damage (18.8%) were the major comorbidities. A high CCI=3+ score was an effective predictor of a high risk of longer LoS and death compared with a low CCI score; and CCI=2 score and CCI=3+ score were efficient predictors of a high risk of elevated hospital costs. Specifically, the most notable LoS-specific comorbidities, and cost-specific comorbidities was dementia, while the most notable mortality-specific comorbidities was moderate or severe renal disease. Conclusion: CCI has significant predictive value for clinical outcomes in IS. Due to population aging, the CCI should be used to identify, monitor and manage chronic comorbidities among immobile IS populations. Copyright: (c) 2021 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/ by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Citation: Liu H, Song B, Jin J, et al. Length of stay, hospital costs and mortality associated with comorbidity according to the Charlson comorbidity index in immobile patients after ischemic stroke in China: a national study. Int J Health

Medical Resource Utilization of Ischemic Stroke Patients with Readmission: A Retrospective Analysis of Hospitalization Data from Beijing Medical Insurance Database

Analysis Of Hospital Charges Of Inpatients With Acute Ischemic Stroke In Beijing, China, 2012-2015

Hospitalization Costs among Immobile Patients with Hemorrhagic or Ischemic Stroke in China: a Multicenter Cross-Sectional Study

Predictors, timing, causes and cost of 30-day readmission after acute ischemic stroke: insights from a Chinese cohort 2015-2018

Analysis of readmission and hospitalization expenditures of patients with ischemic stroke suffering from different comorbidities

Length of Stay, Hospital Costs and Mortality Associated with Comorbidity According to the Charlson Comorbidity Index in Immobile Patients after Ischemic Stroke in China: A National Study.

Patient Readmission for Ischemic Stroke: Risk Factors and Impact on Mortality

Distribution and Predictors of Hospital Charges for Haemorrhagic Stroke Patients in Beijing, China, March 2012 to February 2015: a Retrospective Study

Real-World Costs of Ischemic Stroke by Discharge Status

Hospitalization costs in patients with stroke in southeastern China: a retrospective population-based cohort study, 2019–2022

Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China

Examining the Impact of Rehospitalization on Healthcare Cost of Myocardial Infarction Patients in Beijing: A Retrospective Observational Study

Abstract P251: Estimates and Temporal Trends for US Nationwide 30-Day Hospital Readmission Among Patients With Ischemic Stroke Treated With Thrombolytic Therapy

Correlation factors of hospital stay and hospitalization costs among AIS patients

The impact of DRG on resource consumption of inpatient with ischemic stroke

Medical Service Utilization and Direct Medical Cost of Stroke in Urban China

Health care utilization for patients with stroke: a 3-year cross-sectional study of China’s two urban health insurance schemes across four cities

Regional Differences in Hospital Costs of Acute Ischemic Stroke in China: Analysis of Data From the Chinese Acute Ischemic Stroke Treatment Outcome Registry

Analysis on the hospitalization costs differences and its effects on health outcome among the stroke patients

Comparing the Economic Burden of Ischemic Stroke Patients with and Without Atrial Fibrillation: a Retrospective Study in Beijing, China

Characteristics of Acute Stroke Patients Readmitted to Inpatient Rehabilitation Facilities: A Cohort Study